Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 3Sarcoma 2Other solid neoplasm 2Other hematologic neoplasm 2Myeloid 2Tumor-Agnostic 1Plasma cell 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Advanced Solid Tumors 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interferon-gamma × Other solid neoplasm × Clear all
NCT02614456 2019-11-29

Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors

Fox Chase Cancer Center

Phase 1 Completed
26 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT00002505 2011-05-12

Tumor Cell Vaccine in Treating Patients With Advanced Cancer

Hoag Memorial Hospital Presbyterian

Phase 2 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡